Clinical Trial Detail

NCT ID NCT03581240
Title An Intermediate Expanded Use Trial of DFMO
Recruitment Available
Gender both
Phase Expanded access
Variant Requirements No
Sponsors Giselle Sholler
Indications

neuroblastoma

atypical teratoid rhabdoid tumor

medulloepithelioma

medulloblastoma

ependymoblastoma

Therapies

Eflornithine

Age Groups: adult child

No variant requirements are available.